Sydney Gavlick

Sydney Gavlick is a Research Scientist 2 at Inotiv since January 2022, previously serving as a Research Scientist 1 at the same company. Prior to this role, Sydney worked as an Analytical Chemist at Galera Therapeutics, Inc. from May 2021 to January 2022. Sydney holds a Bachelor of Arts in Chemistry with an emphasis in forensics from Lindenwood University, obtained in May 2021, and an Associate of Science in Biology from Southwestern Illinois College, completed in May 2018.